Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement-Reference-Cited by-同舟云学术

Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement

Published:2022-06-23 Issue:1 Volume:16 Page:66-77
ISSN:1933-6896
Container-title:Prion
language:en
Short-container-title:Prion

Author:

Forloni Gianluigi¹,Roiter Ignazio²,Artuso Vladimiro²,Marcon Manuel³,Colesso Walter³,Luban Elviana³,Lucca Ugo¹,Tettamanti Mauro¹,Pupillo Elisabetta¹,Redaelli Veronica⁴,Mariuzzo Francesco³,Boscolo Buleghin Giulia³,Mariuzzo Alice³,Tagliavini Fabrizio⁴,Chiesa Roberto¹,Ambrosini Anna⁵

Affiliation:

1. Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy

2. Ulss 2 Marca Trevigiana Ca’ Foncello Hospital, Treviso, Italy

3. AFIFF, Treviso, Italy

4. Fondazione IRCCS Istituto Neurologico ”Carlo Besta”, Milano, Italy

5. Fondazione Telethon ETS, Milano, Italy

Funder

This work was supported by Fondazione Telethon

Publisher

Informa UK Limited

Subject

Infectious Diseases,Cell Biology,Cellular and Molecular Neuroscience,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/19336896.2022.2083435

Reference55 articles.

1. Fatal familial insomnia and sporadic fatal insomnia

2. Clinical trials of prion disease therapeutics

3. Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases

4. Patient‐driven search for rare disease therapies: the Fondazione Telethon success story and the strategy leading to Strimvelis

5. Age at onset in genetic prion disease and the design of preventive clinical trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Creutzfeldt–Jakob disease and other prion diseases;Nature Reviews Disease Primers;2024-02-29

2. Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies;Expert Opinion on Therapeutic Targets;2023-06-19

3. Alpha Synuclein: Neurodegeneration and Inflammation;International Journal of Molecular Sciences;2023-03-21